Definium Therapeutics, Inc. - Common Shares (DFTX)

21.92
+0.04 (0.16%)
NASDAQ · Last Trade: May 2nd, 12:25 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
These 3 Psychedelic Stocks Activated After Trump's Executive Ordermarketbeat.com
Via MarketBeat · April 27, 2026
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soarfool.com
Trump is easing approval for psychedelic treatments for mental disorders.
Via The Motley Fool · April 20, 2026
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Namesfool.com
This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.
Via The Motley Fool · March 18, 2026
Definium (DFTX) Q4 2025 Earnings Call Transcriptfool.com
Definium (DFTX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 27, 2026